Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fridrich

Showing results (261-270 of 286) with videos related to

Pageof 29
Sort By:
Plos One|November 2, 2012
In vivo functional requirement of the mouse Ifitm1 gene for germ cell development, interferon mediated immune response and somitogenesisIngeborg Klymiuk, Lukas Kenner, Thure Adler, et al.
Virology Journal|October 1, 2024
Convalescent anti-SARS-CoV-2 plasma for the treatment of patients with COVID-19: a retrospective study RESCOVID-19Miloš Bohoněk, Jan Máca, Jiří Sagan, et al.
Therapeutic Advances in Psychopharmacology|July 7, 2018
Amisulpride augmentation of clozapine for treatment-refractory schizophrenia: a double-blind, placebo-controlled trialThomas R E Barnes, Verity Leeson, Carol Paton, et al.
Bioorganic & Medicinal Chemistry Letters|March 16, 2023
Discovery of a brain-sparing GIRK1/4 inhibitor for pharmacological cardioversion of atrial fibrillationStefan Peukert, Hatice Belgin Gulgeze Efthymiou, Ruowei Mo, et al.
Health Technology Assessment (Winchester, England)|September 5, 2017
Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectivenessThomas Re Barnes, Verity C Leeson, Carol Paton, et al.
The Lancet. Oncology|August 14, 2018
Sorafenib plus topotecan versus placebo plus topotecan for platinum-resistant ovarian cancer (TRIAS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trialRadoslav Chekerov, Felix Hilpert, Sven Mahner, et al.
American Heart Journal|March 31, 2015
Anticoagulant therapy and outcomes in patients with prior or acute heart failure and acute coronary syndromes: Insights from the APixaban for PRevention of Acute ISchemic Events 2 trialJan H Cornel, Renato D Lopes, Stefan James, et al.
Current Biology : CB|September 22, 2023
The Polycomb repressive complex 2 deposits H3K27me3 and represses transposable elements in a broad range of eukaryotesTetsuya Hisanaga, Facundo Romani, Shuangyang Wu, et al.
Eclinicalmedicine|July 9, 2020
Final analysis of a 14-year long-term follow-up study of the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in women from four nordic countriesSusanne K Kjaer, Mari Nygård, Karin Sundström, et al.
ACS Medicinal Chemistry Letters|December 20, 2023
Transaminases Provide Key Chiral Building Blocks for the Synthesis of Selective M1/M4 AgonistsChristopher G Thomson, Kelly Boss, Amy Calhoun, et al.
Pageof 29

Showing results (261-270 of 286) with videos related to

Sort By:
Pageof 29
Plos One|November 2, 2012
In vivo functional requirement of the mouse Ifitm1 gene for germ cell development, interferon mediated immune response and somitogenesisIngeborg Klymiuk, Lukas Kenner, Thure Adler, et al.
Virology Journal|October 1, 2024
Convalescent anti-SARS-CoV-2 plasma for the treatment of patients with COVID-19: a retrospective study RESCOVID-19Miloš Bohoněk, Jan Máca, Jiří Sagan, et al.
Therapeutic Advances in Psychopharmacology|July 7, 2018
Amisulpride augmentation of clozapine for treatment-refractory schizophrenia: a double-blind, placebo-controlled trialThomas R E Barnes, Verity Leeson, Carol Paton, et al.
Bioorganic & Medicinal Chemistry Letters|March 16, 2023
Discovery of a brain-sparing GIRK1/4 inhibitor for pharmacological cardioversion of atrial fibrillationStefan Peukert, Hatice Belgin Gulgeze Efthymiou, Ruowei Mo, et al.
Health Technology Assessment (Winchester, England)|September 5, 2017
Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectivenessThomas Re Barnes, Verity C Leeson, Carol Paton, et al.
The Lancet. Oncology|August 14, 2018
Sorafenib plus topotecan versus placebo plus topotecan for platinum-resistant ovarian cancer (TRIAS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trialRadoslav Chekerov, Felix Hilpert, Sven Mahner, et al.
American Heart Journal|March 31, 2015
Anticoagulant therapy and outcomes in patients with prior or acute heart failure and acute coronary syndromes: Insights from the APixaban for PRevention of Acute ISchemic Events 2 trialJan H Cornel, Renato D Lopes, Stefan James, et al.
Current Biology : CB|September 22, 2023
The Polycomb repressive complex 2 deposits H3K27me3 and represses transposable elements in a broad range of eukaryotesTetsuya Hisanaga, Facundo Romani, Shuangyang Wu, et al.
Eclinicalmedicine|July 9, 2020
Final analysis of a 14-year long-term follow-up study of the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in women from four nordic countriesSusanne K Kjaer, Mari Nygård, Karin Sundström, et al.
ACS Medicinal Chemistry Letters|December 20, 2023
Transaminases Provide Key Chiral Building Blocks for the Synthesis of Selective M1/M4 AgonistsChristopher G Thomson, Kelly Boss, Amy Calhoun, et al.
Pageof 29